NCT04981509 2026-03-18
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Recruiting
National Cancer Institute (NCI)
Genentech, Inc.
M.D. Anderson Cancer Center
Hospital of Macerata
LG Chem